These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 8402230)

  • 21. IL-5 and its receptor: which role do they play in the immune response?
    Koike M; Takatsu K
    Int Arch Allergy Immunol; 1994 May; 104(1):1-9. PubMed ID: 7950399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interleukin 5 (IL-5) and its receptor.
    Takatsu K
    Microbiol Immunol; 1991; 35(8):593-606. PubMed ID: 1753880
    [No Abstract]   [Full Text] [Related]  

  • 23. Dual function of eosinophils in pathogenesis and protective immunity against parasites.
    Capron M
    Mem Inst Oswaldo Cruz; 1992; 87 Suppl 5():83-9. PubMed ID: 1342722
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interleukin-3 (IL-3) and granulocyte-macrophage colony-stimulating factor (GM-CSF) can induce differentiation of chronic B cell leukemia expressing the alpha subunit of IL-3 and GM-CSF receptor.
    Shiiba M; Takaki S; Takatsu K
    Int Arch Allergy Immunol; 1996; 111 Suppl 1():12-5. PubMed ID: 8906104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Requirement of IL-5 for induction of autoimmune hemolytic anemia in anti-red blood cell autoantibody transgenic mice.
    Sakiyama T; Ikuta K; Nisitani S; Takatsu K; Honjo T
    Int Immunol; 1999 Jun; 11(6):995-1000. PubMed ID: 10360974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of IL-5 for mature B-1 cells in homeostatic proliferation, cell survival, and Ig production.
    Moon BG; Takaki S; Miyake K; Takatsu K
    J Immunol; 2004 May; 172(10):6020-9. PubMed ID: 15128785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression.
    Gregory B; Kirchem A; Phipps S; Gevaert P; Pridgeon C; Rankin SM; Robinson DS
    J Immunol; 2003 Jun; 170(11):5359-66. PubMed ID: 12759409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eosinophils negatively regulate eosinophilopoiesis by decreasing IL-5 levels.
    Enokihara H; Koike T; Nakamura Y; Yamashiro K; Tsuruoka N; Saito K; Furusawa S
    Int Arch Allergy Immunol; 1996; 111 Suppl 1():2-4. PubMed ID: 8906102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Current concepts of B cell modulation.
    Matsuda T; Yamasaki K; Taga T; Hirano T; Kishimoto T
    Int Rev Immunol; 1989; 5(2):97-109. PubMed ID: 8691054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interleukin-5 in growth and differentiation of blood eosinophil progenitors in asthma: effect of glucocorticoids.
    Kuo HP; Wang CH; Lin HC; Hwang KS; Liu SL; Chung KF
    Br J Pharmacol; 2001 Dec; 134(7):1539-47. PubMed ID: 11724761
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Eotaxin triggers eosinophil-selective chemotaxis and calcium flux via a distinct receptor and induces pulmonary eosinophilia in the presence of interleukin 5 in mice.
    Rothenberg ME; Ownbey R; Mehlhop PD; Loiselle PM; van de Rijn M; Bonventre JV; Oettgen HC; Leder P; Luster AD
    Mol Med; 1996 May; 2(3):334-48. PubMed ID: 8784786
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergic diseases: From bench to clinic - Contribution of the discovery of interleukin-5.
    Yanagibashi T; Satoh M; Nagai Y; Koike M; Takatsu K
    Cytokine; 2017 Oct; 98():59-70. PubMed ID: 28863833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin-5, eosinophilic diseases and therapeutic intervention.
    Zabeau L; Gevaert P; Bachert C; Tavernier J
    Curr Drug Targets Inflamm Allergy; 2003 Dec; 2(4):319-28. PubMed ID: 14561151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of p59fynT in interleukin-5 receptor signaling.
    Appleby MW; Kerner JD; Chien S; Maliszewski CR; Bondada S; Perlmutter RM; Bondadaa S [corrected to Bondada S]
    J Exp Med; 1995 Sep; 182(3):811-20. PubMed ID: 7650487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Growth and differentiation of eosinophils--special reference to IL-5 and its receptor].
    Akutsu I; Takatsu K
    Nihon Rinsho; 1993 Mar; 51(3):557-64. PubMed ID: 8492427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production.
    Tominaga A; Takaki S; Koyama N; Katoh S; Matsumoto R; Migita M; Hitoshi Y; Hosoya Y; Yamauchi S; Kanai Y
    J Exp Med; 1991 Feb; 173(2):429-37. PubMed ID: 1988543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [IL-5-and its receptor--the role of IL-5 in the development of hematopoietic cells in the long-term bone marrow cultures].
    Katoh S; Takatsu K
    Nihon Rinsho; 1992 Aug; 50(8):1795-801. PubMed ID: 1433970
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of IL-9 in the pathophysiology of allergic diseases.
    Soussi-Gounni A; Kontolemos M; Hamid Q
    J Allergy Clin Immunol; 2001 Apr; 107(4):575-82. PubMed ID: 11295641
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-18 regulates both Th1 and Th2 responses.
    Nakanishi K; Yoshimoto T; Tsutsui H; Okamura H
    Annu Rev Immunol; 2001; 19():423-74. PubMed ID: 11244043
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of IL-5 and its receptor in immune system].
    Tominaga A
    Tanpakushitsu Kakusan Koso; 1991 May; 36(7):1177-83. PubMed ID: 1871348
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.